Mind Medicine Inc. (NASDAQ:MNMD) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET
Company Participants
Rob Barrow - Chief Executive Officer
Schond Greenway - Chief Financial Officer
Dan Karlin – Chief Medical Officer
Conference Call Participants
Charles Duncan - Cantor Fitzgerald
Navin Jacob - RBC Capital
Elemer Piros - EF Hutton
Francois Brisebois – Oppenheimer
Jonathan Aschoff - ROTH MKM
Operator
Good afternoon, and welcome to the Mind Medicine Second Quarter 2023 Financial Results and Corporate Update Conference call. Currently, all participants are in listen-only mode. This call is being webcast live on the Investors and Media section of MindMed's website at mindmed.co and a recording will be available after the call.
For opening remarks, I would like to introduce Rob Barrow, CEO of MindMed. Please go ahead.
Rob Barrow
Thank you, and good afternoon, everyone. Welcome to our second quarter 2023 financial results and corporate update conference call. The press release reporting our financial results is available in the Investors and Media section of MindMed's website and our quarterly report on Form 10-Q for the quarter ended March 31, 2023, will be filed today with the Securities and Exchange Commission.
Joining me today is Schond Greenway, our Chief Financial Officer; Dr. Dan Karlin, our Chief Medical Officer; and Dr. Miri Halperin Wernli, our Executive President.
During today's call, we'll be making certain forward-looking statements including without limitation, statements about the potential safety, efficacy and regulatory and clinical progress of our product candidates, financial projections and our future expectations, plans, partnerships and prospects. These statements are subject to various risks such as changes in market conditions, difficulties associated with research and development and regulatory approval processes that are described in the filings made with the SEC, including the most recent annual report on Form 10-K and quarterly report on Form 10-Q.
- Read more current MNMD analysis and news
- View all earnings call transcripts